Story

On air. The free wire runs 15 minutes behind live. See pricing

World, crypto, finance and tech news, scored for impact.

MarketsPR NewswireFiled 3 days ago

Medtronic (MDT) to acquire Contego Medical, expanding access to next-generation carotid therapies

Open the sourceReported by PR Newswire, prnewswire.com, 16 November 2026, by PR Newswire

Not investment advice. Muhabbit scores how much a story may matter, not which way to trade.

Medtronic (NYSE: MDT) said it intends to acquire privately held Contego Medical, adding next-generation carotid artery and peripheral vascular technologies to its portfolio. The deal, announced Nov. 16, 2026, expands Medtronic's access to stroke-prevention devices amid growing demand for minimally invasive carotid therapies. Financial terms were not disclosed in the announcement. The acquisition is subject to customary closing conditions, including regulatory clearance. Investors will watch for deal terms and regulatory timelines, plus how quickly Contego's products can be folded into Medtronic's vascular franchise.

Muhabbit's AI wrote this summary in its own words from PR Newswire's report. It can get details wrong, so check the source.

Named in this story

Contego Medical, Medtronic (MDT), Galway, Ireland

A linked name opens that asset's sentiment page.